当前位置:首页 >财报库 > 报告详情

哈门那公司HUMANA(HUM)2026年第一季度财报(10-Q)「NYSE」(英文版)(49页).pdf

上传人: Kell****reet 编号:1226767 2026-05-06 49页 541.63KB

下载:

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-QQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended March 31,2026 ORTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For

2、the transition period from to Commission file number 1-5975HUMANA INC.(Exact name of registrant as specified in its charter)Delaware61-0647538(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)101 East Main StreetLouisville,Kentucky 40202(Address of prin

3、cipal executive offices,including zip code)(502)580-1000(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading SymbolName of each exchange on which registeredCommon stock,$0.16 2/3 par valueHUMNew York Stock ExchangeIndi

4、cate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject to such filing r

5、equirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months(or for such shorter period that the registrant was required to

6、 submit such files).Yes No Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller reporting company,or an emerging growth company.See the definitions of“large accelerated filer,”“accelerated filer,”“smaller reporting company,

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **财务表现**:2026年Q1营收396.48亿美元(同比+23.5%),净利润11.86亿美元(同比-4.7%);每股收益9.83美元(同比-4.6%)。 2. **重大收购**:以9.08亿美元现金收购MaxHealth,初步分配8亿美元至商誉。 3. **投资证券**:持有投资证券176.4亿美元(2025年末161.96亿美元),97%为投资级,未实现亏损9.7亿美元(主因利率上升)。 4. **债务与回购**:总债务132.74亿美元;2026年Q1回购60万股,耗资1.03亿美元,剩余回购授权27亿美元。 5. **风险与合规**:Medicare业务占营收86%,面临CMS风险调整审计(RADV)及数据合规挑战。
**Humana业绩如何?** **投资证券风险大吗?** **Medicare合同更新了吗?**
客服
商务合作
小程序
服务号
折叠